Clinical Trial Update: PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated PG2 for improving cancer-related fatigue in advanced cancer patients under standard palliative care, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue

Drugs mentioned

• PG2

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer-related Fatigue | Phase 4 | Status: COMPLETED